NICE Cost-Recovery-Plan Pause Is Welcome News For UK Industry
Executive Summary
The UK National Institute for Health and Care Excellence will wait for the government to finalize its life sciences strategy before deciding on whether to go ahead with its plan to levy a fee for technology appraisals. Pharmaceutical and medtech companies say the delay by NICE will allow more time for their concerns over the proposal to be explored.